Long-term efficacy and safety of Botulinum toxin type A in refractory chronic daily headache

dc.contributor.authorErdemoglu, AK
dc.contributor.authorVarlibas, A
dc.date.accessioned2020-06-25T17:35:20Z
dc.date.available2020-06-25T17:35:20Z
dc.date.issued2003
dc.departmentKırıkkale Üniversitesi
dc.description11th Congress of the International-Headache-Society -- SEP 12-16, 2003 -- ROME, ITALY
dc.description.abstracten_US
dc.description.sponsorshipInt Headache Socen_US
dc.identifier.citationclosedAccessen_US
dc.identifier.endpage633en_US
dc.identifier.issn0333-1024
dc.identifier.issue7en_US
dc.identifier.startpage633en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12587/3094
dc.identifier.volume23en_US
dc.identifier.wosWOS:000185115000239
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBlackwell Publishing Ltden_US
dc.relation.ispartofCephalalgia
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleLong-term efficacy and safety of Botulinum toxin type A in refractory chronic daily headacheen_US
dc.typeConference Object

Dosyalar